The nonclassicalextracellular signal-related kinase 5 (ERK5) mitogen-activatedprotein kinase pathway has been implicated in increased cellular proliferation,migration, survival, and angiogenesis; hence, ERK5 inhibition maybe an attractive approach for cancer treatment. Here, MAPK7 is linked to cancer.